Skip to content

Muscle Mass or Muscle Function as a prédictive Tools for Outtcomme in Chronic Dialysis Patients

Retrospective Study : Muscle Mass or Muscle Function as a prédictive Tools for Outtcomme in Chronic Dialysis Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03845452
Enrollment
187
Registered
2019-02-19
Start date
2016-01-01
Completion date
2019-01-31
Last updated
2020-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chrnoic Haemodialysis Patients

Keywords

chronic kidney disease, muscle strength, muscle mass, lean body mass, physical activity

Brief summary

Aim of this study is to compare the association of muscle mass and functionality with mortality among chronic haemodialysis * the involvement of malnutrition inflammation and atherogenesis syndrome (increase in C reactive protein and decrease in serum albumin) on voluntary muscle strength impairment and phyiscal activity. * the relationship between voluntary muscle strength and mortality * the relationship between voluntary muscle strength and physical activity

Detailed description

Aim of this study is to compare the association of muscle mass and functionality with mortality among chronic haemodialysis * the involvement of malnutrition inflammation and atherogenesis syndrome (increase in C reactive protein and decrease in serum albumin) on voluntary muscle strength impairment and phyiscal activity. * the relationship between voluntary muscle strength and mortality * the relationship between voluntary muscle strength and physical activity

Interventions

None listed

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* chronic kidney disease patient with extrarenal replacement therapy by hemodialysis for at least 3 months * stable clinical condition (absence of infection, stroke or acute decompensation)

Exclusion criteria

* chronic kidney disease without extrarenal replacement therapy * history of renal transplantation

Design outcomes

Primary

MeasureTime frameDescription
Mortality at 2 years2 yearsMortality at 2 years

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026